The Trendlines Group Ltd.

Research The Trendlines Group Ltd. (42T.SI) on Bullrun: market cap SGD 77.02M, P/E 4.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SGD 77.02M; P/E is 4.9.

Peer valuation comparison

Latest P/E is 4.9x versus a Financial Services sector median of 13.04x (62.4% below).

Latest P/E is 4.9x versus a Israel median of 21.43x (77.1% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 350.00KUSD 1.92M-USD 9.03M-714.3%0USD 4.82MUSD 5.35MUSD 78.31M
FY2024USD 1.72M-USD 9.43M-USD 8.86M-100.4%-0.01USD 4.97MUSD 4.15MUSD 68.55M
FY2023USD 4.50M-USD 34.00M-USD 6.42M-17.6%0.04USD 6.11MUSD 4.64MUSD 70.89M
FY2022USD 3.58M-USD 14.48M-USD 15.04M-107.1%-0.02USD 4.57MUSD 4.85MUSD 96.99M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-10SGD 77.02M4.9n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SGD.

About The Trendlines Group Ltd.

The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, medtech, clean technology, agrifood, agritechnology, healthcare, life sciences, with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is The Trendlines Group Ltd.'s market cap?

The Trendlines Group Ltd.'s market capitalization is SGD 77.02M.

What is The Trendlines Group Ltd.'s P/E ratio?

The Trendlines Group Ltd.'s price-to-earnings (P/E) ratio is 4.9.

What does The Trendlines Group Ltd. do?

The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, medtech, clean technology, agrifood, agritechnology, healthcare, life sciences, with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore.